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Summary 
Mice homozygous for the mutant allele scid (severe combined immunodeficiency)  have been described 
as excellent models for Pneumocystis carinii (Pc) pneumonia (PCP),  a major health problem in 
patients with acquired immune deficiency syndrome (AIDS) and other immunodeficiency states. 
Other microorganisms have been shown to infect AIDS patients simultaneously with Pc, but 
whether one opportunist is able to directly influence the pathogenicity of another has not been 
determined previously. We have deliberately coinfected scid mice (with extant Pc infection) with 
a variety of primarily pneumotropic viruses and bacteria and have identified pneumonia virus 
of mice as causing a dramatic increase in the density of Pc organisms and the morbidity due 
to PCP in immunodeficient scid mice. This finding has clinical significance in the management 
of PCP,  in that the identification and treatment of coinfecting pneumotropic pathogens may 
be as important as treatment targeted at Pc.  A  search for other synergistic (or antagonistic) 
microorganisms and determination of their mechanism(s) of action in altering the progression 
of PCP is indicated. 
p atients with AIDS commonly develop and die from oppor- 
tunistic infections (1).  The spectrum of infectious dis- 
eases seen in AIDS patients includes those caused by viruses, 
bacteria, fungi, and protozoa (2). Chief among these pathogens 
is the fungus (3, 4) Pneumocystis carinii (Pc), with an inci- 
dence of '~80%  in AIDS patients (5).  Mixed infections in- 
volving Pc have been described in both AIDS (Pc plus CMV, 
Mycobacteriura spp.  or Legionella pneumophila)  [2, 6]) and in 
malnourished children (where coinfecting organisms include 
Toxoplasma gondii, Cryptosporidium, Candida sp., Cryptococcus 
neoformans, Mycobacterium sp., Chlamydia trachomatis, CMV, 
herpes simplex, herpes zoster, EBV, and respiratory syncytial 
virus [KSV]) (7). Whether the presence of a specific coinfec- 
tious organism is neutral, antagonistic, or synergistic in in- 
teraction with Pc has been largely unaddressed. However, one 
retrospective study of patients with HIV-related pneumonia 
concluded that coinfection by CMV (the most commonly 
isolated viral copathogen in AIDS) did not adversely affect 
the prognosis of patients with Pneumocystis carinii pneumonia 
(PCP)  (6). 
In our original studies on PCP in scid mice (8), the lon- 
gevity ofscid mice reared in a barrier facility was greater than 
that of mice reared in a conventional room, although PCP 
was the principle cause of morbidity in both environments. 
Among  14  species  of bacteria,  mycoplasma,  and  viruses 
checked,  the  only  identified  difference in  pneumotropic 
microorganisms between the two rooms was the persistent 
finding of Pasteurella pneumotropica (Pp) in the conventional 
room, although pneumotropic viruses such as pneumonia virus 
of mice (PVM) had historically also been found on rare occa- 
sions. We thus initiated experiments involving the deliberate 
challenge of Pc-infected scid mice with various microorganisms 
with tropisms primarily or secondarily directed toward tissues 
of the respiratory tract to determine whether such coinfec- 
tion would exacerbate PCP. 
Materials and Methods 
Mice.  Immunodeficient mutant scid/scid  (hereafter termed scic  0 
mice were obtained originally from the Institute for Cancer Re- 
search (Philadelphia, PA) on inbred strain background C.B-17/Icr. 
The scid mutation was transferred by us to several  standard inbred 
strains by greater that 10 backcrosses, and the congenic strains 
BALB/cBy-scid and C3H/HeSn-sc/d  were then propagated  by brother 
x  sister matings. All scid mice maintained in our colony develop 
spontaneous PCP and die at median ages of 20 wk (BALB-scid) 
and 24 wk (C3H-scid). Additional details on the genetics, natural 
history, and pathology of PCP in scid mice have been described (8). 
Homozygous scid and congenic +/+ mice for these experiments 
were inoculated with specific  microorganisms and thereafter main- 
tained in polycarbonate cages with filter tops until necropsy. All 
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logical safety cabinet, and all cages, bedding, feed, and water were 
autoclaved. The number of mice studied in each experiment is in- 
dicated as the denominator (number at risk) in the morbidity data 
presented (see Fig.  1 and Table 1). 
Histopathology.  At  necropsy,  lungs  were removed,  fixed  in 
Bouin's solution, embedded in para~n,  sectioned at 5/~M,  and 
stained with hematoxylin and eosin (H&E) or Grocott's methen- 
amine silver (GMS) and light green (I,(3). Tissue sections were evalu- 
ated for the presence and intensity of PCP-related histopathology 
and cyst levels as described previously (8). 
Immunohistochemistry.  PVM andPc were identified on serial sec- 
tions of infected scid lung by capillary gap technology using a ro- 
botic immunohistochemistry workstation (9)  (Code-On; Fisher 
Scientific, Pittsburgh, PA). Paraffin sections to be stained for PVM 
were predigested for 30 min in a solution of 0.25% crude pan- 
creatic type II trypsin (Sigma Immunochemicals, St. Louis, MO) 
in 0.02%  CaC12, followed by overnight incubation with poly- 
clonal rat anti-PVM antiserum. Sections were then incubated for 
30  rain  with  biotinylated  goat  anti-rat  Ig,  then  streptavidin- 
horseradish  peroxidase  (SA-HPO;  Southern Biotechnology As- 
sociates, Birmingham, AL), and finally with chromagen 3-amino, 
9-ethylcarbazole (AEC; Biomeda, Foster City, CA). Pc was revealed 
(without trypsinization) on adjacent  serial sections by 30-rain in- 
cubations with polyclonal mouse anti-Pc  (10), biotinylated goat 
anti-mouse Ig r, and finally SA-HPO and AEC as above. Stained 
slides were viewed and representative fields were digitized using 
an Olympus research microscope equipped with a Sony DXC-930 
CCD color video camera and a Macintosh Ilci computer with a 
Scion LG-3 8-bit grayscale frame grabber (Scion Corp., Frederick, 
MD). Acquisition and initial manipulation of the images were done 
using the public domain National Institutes of Health (NIH) Image 
1.47 program written by W. Rasband (available by anonymous In- 
teruet FTP from ziplv.nimh.nih.gov  ). The superimposed images 
of PVM-  and Pc-stained  tissue  (from adjacent  serial sections  of a 
dually infected scid lung; see Fig.  2) were produced by merging 
the NIH Image-produced TIFF files using Adobe Photoshop fol- 
lowed by printing on a ColorTone dye-sublimation printer (GCC 
Technologies,  Bedford, MA). 
Microorganisms and Inoculation Procedures.  The following microor- 
ganisms  were investigated  to determine their ability to alter the 
course of PCP in scid mice. Recipient mice were 6-10-wk-old at 
time of inoculation. Unless otherwise stated, C3H mice were used 
in these experiments because of the relative hardiness and breeding 
success of C3H-scid mice among various  congenic scid stocks  in 
our colony. 
PVM.  200 fluorescent focus units (FFU, see below) of PVM 
were inoculated intranasally (11) into C3H-scid and +/+  mice. The 
PVM inoculum was a pooled lung homogenate from naturally in- 
fected athymic mice (12) that was isolated and quantified in BHK 
21 cell cultures as previously described (11). 
Mouse Hepatitis Virus-Y (MHV-Y).  The isolation and charac- 
terization of strain MHV-Y was described by Barthold et al. (13). 
Isolate No.  78318 was passaged  in mycoplasma-free  NCTC1469 
cell cultures (American Type Culture Collection [ATCC], Rock- 
ville, MD).  100 median tissue  culture infectious doses (TCIDs0) 
of this isolate were inoculated intranasally into C3H-scid and +/+ 
mice. 
RSV.  RSV (VK-26) was grown on HEIy2 (CCL-23) cells (both 
obtained from ATCC).  105 TCIDs0 of RSV were inoculated in- 
tranasally  into BALB/c-scid and  +/+  mice. Mice of the BALB/c 
background were used in this experiment because of the known 
susceptibility of BALB/c and resistance of C3H mice to RSV (14). 
Sendai Virus (S V).  SV isolate No. 771076 was derived at Yale 
University (15) and used in the form of an infected lung homoge- 
nate from specific pathogen-free, random-bred weanling mice. 100 
FFU were inoculated intranasally into C3H-scid and  +/+  mice. 
P/~  The Pp inoculum was obtained from Dr. H. Bedigian  at 
The Jackson Laboratory (Bar Harbor, ME), and was cultured and 
frozen at  - 70~  until needed. C3H-scid and  +/+  mice received 
an intranasal  inoculum of 1.1  x  107 CFU per mouse. 
Postinoculation Assessment of Infection.  Since scid mice lack the 
capability of producing normal antibody responses and normal +/+ 
mice can clear infectious microorganisms, both serology and mi- 
croorganism cultures were used to confirm successful inoculation. 
Serology.  Antibody was detected in 1:10 diluted serum by an 
indirect fluorescent antibody assay (IFA) as previously described 
(16, 17) using infected BHK21 cells for PVM and SV, NCTC1469 
cells for MHV-Y, and Hep2 cells for RSV. In all cases, the secondary 
antibody was FITC-conjugated goat anti-mouse Ig (Antibodies, 
Inc., Davis,  CA). 
Virus Isolation and Titration.  Analyses for PVM and SV were 
performed by inoculating BHK21 cells grown on chamber slides 
(Lab-Tek; Miles Scientific Division, Naperville, IL) with superua- 
tants of test lung homogenates. After 6 d of incubation, these cul- 
ture slides were processed for IFA. Virus titers were expressed as 
log10 FFU per gram of lung. 
Pp Cultures.  Groups of mice were necropsied at 1, 2, and 3 mo 
after intranasal inoculation. Nasopharyngeal washes were obtained 
and plated on blood agar media, and growth was documented after 
24 h  of culture. 
Statistics.  Results were expressed as the arithmetic mean _+ SE 
of the mean. Two-tailed Student's t tests  (for comparison of un- 
paired samples) were performed, and p values ~<0.05 were consid- 
ered to be significant. 
Results 
Synergistic Effect of PVM on PCP.  All 26 C3H-scid  mice 
inoculated with PVM died or were necropsied when mor- 
bidly ill 25-28 d  after infection (dpi) (Fig.  1 A).  No mor- 
bidity was exhibited by any of the noninoculated scid mice 
or by treated or untreated C3H-+/+  mice. Histological ex- 
amination revealed that morbidity was associated with pul- 
monary pathology typical of PCP (8). Characteristic alveoli- 
filling foamy matrix comprised primarily of Pc organisms, 
activated macrophages, remnants of phagocytic cells, and pro- 
teinaceous exudate was found to be extensive in distribution 
and density. Thickening of alveolar interstitium was also pro- 
nounced. The extent of pulmonary pathology (Fig. 1 B) was 
significantly greater in PVM-treated scid mice than in their 
noninoculated counterparts.  Neither PVM-treated  nor un- 
treated C3H-+/+  mice had significant pulmonary pathol- 
ogy, although some of the PVM-treated  +/+  mice did ex- 
hibit occasional intraalveolar inflammatory cells, minor focal 
hyperemia, and hemorrhage characteristic of PVM infection 
(12, 17). Mutant scid mice inoculated with PVM had nearly 
five times greater density of Pc cysts than noninoculated con- 
trol scid mice (Fig.  1 C). As expected, no Pc cysts were ob- 
served in either PVM-inoculated or noninoculated C3H-+/+ 
mice. 
To test the ef~cacy of viral inoculation, lungs were removed 
at necropsy (25-28 dpi) and PVM virus was titrated.  Virus 
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Figure  1.  Analysis of Pc-related pathology and morbidity in C3H-scid 
mice after inoculation with PVM. (/1) Percent morbidity (No. dead or 
moribund/total  No.  at  risk).  (B)  Lung  pathology.  (c)  Pc  density 
(cysts/mm2). (D) PVM virus recovery (logl0 FFU/gram of tissue). No. 
of positive >  2.5 log10 FFU) mice/No, tested. 
recoveries <2.5 logl0 FFU per gram of lung were considered 
negative.  13 of 14 (93%) inoculated scid mice were positive 
(Fig.  1 D), whereas none of the noninoculated scid mice or 
the inoculated +/+  mice was positive,  indicating that: (a) 
scid mice were free of PVM before experimental infection; 
and (b) wild-type mice, but not the immunodeficient  scid mice, 
were able to clear PVM. Viral serology was also conducted. 
All of 22 inoculated +/+  mice were seropositive  whereas 
none of 14 noninoculated +/+  mice and none of 14 inocu- 
lated scid mice was positive. These data document lack of prior 
infection and successful intranasal inoculation. Overall, these 
findings demonstrate that PVM directly increases infection 
and morbidity by Pc organisms. 
As demonstrated by microscopy and image analysis, PVM 
and Pc in dually infected scid lungs were distributed indepen- 
dently of each other at the microanatomical level. PMV was 
detected primarily within the cytoplasm of alveolar and bron- 
chiolar epithelial cells, whereas Pc was found extracellularly 
but in close proximity to the alveolar epithelial lining. Clusters 
of Pc  and  PVM-containing cells  were  diffusely  scattered 
throughout the pulmonary parenchyma but in general did 
not colocalize (Fig. 2). PVM could not be detected in the 
lungs of scid mice that were not deliberately  infected. 
Microorganisms Not Producing a Synergistic Effect on PCP. 
Four other pneumotropic microorganisms besides PVM were 
evaluated for possible synergism with Pc. There was no evi- 
dence of exacerbation of PCP in any of the following dually 
infected scid mice (Table 1). 
MHV-Y.  Morbidity signs were exhibited by all 25 inoc- 
ulated C3H-scid mice allowed to age and survival ranged from 
31 to 59 dpi. This morbidity was not related to heightened 
presence of Pc organisms as both cyst density (Table 1) and 
histopathology associated with PCP (data not shown) were 
similar among infected and noninfected scid mice. Only one 
of four noninfected scid mice became moribund (at 34 dpi); 
the remaining thrifty mice were necropsied at 45 dpi. Sero- 
logical tests of C3H-+/+  mice confirmed the success of in- 
tranasal MHV-Y infection. As expected,  scid mice failed to 
generate detectable  antibody. 
RSV.  RSV did not significantly exacerbate Pc cyst den- 
sity, pathogenicity, or morbidity from Pc in BALB/c-scid mice. 
6 out of 16 RSV-inoculated and 2 out of 4 noninoculated 
scid mice became ill and were necropsied between 33 and 55 
dpi. Serological  tests of BALB/c-+/+  mice confirmed the 
success of the RSV inoculation. 
SV.  All 20 scid and eight +/+  mice inoculated with SV 
became morbidly ill by 12 dpi; all noninoculated control mice 
remained thrifty and were necropsied in parallel The 19 scid 
mice tested had recoverable SV 7-12 dpi with titers 5.1-5.5 
log10 FFU.  Two of the inoculated  +/+  mice were virus 
positive (4.8  _+ 0.8 log10 FFU) at 7 dpi; one  +/+  assayed 
at 12 dpi was virus negative. There was no significant differ- 
ence in the density of Pc cysts (Table 1) or in PCP-associated 
pulmonary histopathology (data  not shown) between SV- 
infected and uninfected scid mice. Because of the rapidity of 
disease development after this dose of SV, there may have been 
insu~cient time to alter  the pathogenesis of PCP. 
Pp.  By 30 dpi, 4 of 24 Pp-inoculated scid mice, but none 
ofll noninoculatedscidand none of 8 inoculated +/+  mice, 
had died. This slightly enhanced morbidity was not associated 
with increased presence of Pc (Table 1) or characteristic PCP 
histopathology (data  not shown). Pp was cultivated from 
nasopharyngeal washes from one of nine uninoculated and 
approximately  three  fourths  of  inoculated  scid  mice 
(X  2 =6.69; p <.01). Although not exacerbating PCP, the in- 
creased morbidity found in Pp-inoculated scid mice may par- 
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clusters and arrows) or anti-Pc (white  clusters and arrows) (x260). 
tially explain the reduced longevity of scid mice in the con- 
ventional versus  barrier facilities  described in the introduction. 
Discussion 
The findings presented here constitute the first evidence 
of a fatal synergism between a coinfective pneumotropic mi- 
croorganism and Pc. PVM, alone among the microorganisms 
tested, caused an increase in the density of Pc organisms, an 
increase in the severity of histopathologically  defined PCP, 
and earlier morbidity than those ofscid mice not coinfected. 
The uniqueness of PVM's influence is suggested by the ob- 
servations that MHV-Y, SV, and Pp were infective and caused 
morbidity but did not increase the density of Pc or augment 
the severity of PCP. Coinfection with human RSV was not 
detrimental to scid mice. That scid mice (deficient in both 
ceU-mediated and humoral immunity) were readily infected 
with PVM (considered an apathogenic virus) is not surprising 
based on earlier studies of the respiratory disease produced 
in T cell-deficient nude (nu) mice singularly challenged with 
PVM (12). In contrast with this fatal synergism of PVM and 
Pc, Pesanti (18) described a protective effect of preexisting 
Pseudomonas pneumonitis on the development of glucocorti- 
coid-induced  PCP. 
Some histopathological hallmarks of  both PVM and Pc in- 
fection are similar (interstitial  pneumonitis with a prepon- 
derance of  macrophages), yet each has unique characteristics. 
PVM infection of an immunocompromised  host has marked 
intraalveolar hemorrhage and substantial fibrin deposition, 
whereas PCP typically has an extensive intraalveolar accumu- 
lation of trophozoite-rich  foamy matrix. It should be em- 
phasized that all dually infected scid mice necropsied had typ- 
ical PCP pathology.  The hallmarks of PVM infection were 
seen only in diminished form in less than a quarter of the cases. 
At present, we can only speculate regarding the possible 
mechanisms underlying the synergism of PVM and Pc. We 
demonstrated that  PVM  and  Pc  were  diffusely  scattered 
throughout the lung parenchyma,  but  only infrequently 
colocalized. Thus, a contact-dependent effect of PVM on en- 
hancing the proliferation of  Pc organisms seems unlikely. The 
possibility that PVM could sufficiently alter the biochemical 
microenvironment  (pH, metabolic factors, etc.) to the benefit 
of  Pc should be considered. Alternatively,  PVM may detrimen- 
tally affect the number or function of alveolar macrophages, 
the principle means of controlling Pc organisms in scid mice. 
Since macrophages  are dominant in the inflammatory responses 
to both Pc and FVM,  infection by PVM may saturate the 
capacity for production, immigration, or activation of these 
phagocytes, resulting in increased numbers of Pc. Also, as 
morbidity  in  PCP  seems  to  be  related  to  pulmonary 
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Organism  Recipients  Inoculated  Infection  Morbidity  Pc Cysts  Probability 
MHV-Y  scid  +  0%  (19) S*  100% (25)*  118  +  37 (21)s  >.5  (NS)II 
-  0%0  (3)  25%  (4)  108  _+  15 (3) 
+/+  +  86%  (7)  12.5%  (8)  0.9  _+  .6  (7) 
-  0%0  (3)  0%  (3)  0.7  +_  .7  (3) 
RSV  scid  +  6%  (16) S  38%  (16)  339  +  41 (16)  <.2 (NS) 
-  0%  (4)  50%  (4)  625  _+ 334 (4) 
+/+  +  83%  (6)  0%  (6)  0 
-  0%  (2)  0%  (2)  o 
SV  scid  +  100%  (19) C  100%  (20)  503  _+  84  (19)  <.4  (NS) 
-  0%  (4)  0%  (22)  409  _+ 72 (22) 
+/+  +  67%  (3)  100% (8)  0.6  _+  .6 (3) 
-  ND  0%  (9)  0  (6) 
Pp  scid  +  72%  (18) C  17%  (24)  212  __  44 (19)  <.4  (NS) 
-  11%  (9)  0%  (11)  303  -+  86  (9) 
+/+  +  42%  (12)  0%  (8)  1  _+  1 (12) 
-  0%  (8)  0%  (6)  0.3  _+  .3  (8) 
* Percent infected (No.  tested) based on serology  (S) or culture 
t Percent  mice dead (No.  at risk). 
s Pc cysts/mm  2 (mean  +  SEM [n]). 
II Probability  (Student's  t test). 
(c). 
insufficiency associated with both thickening of the alveolar 
septa as well as dense alveolar obstruction (organisms, desqua- 
mated epithelia, and active and remnant phagocytic cells), 
any factor causing additional recruitment, proliferation, and 
activation of macrophages may be detrimental to the host. 
In support of this scenario, we have previously shown that 
scid mice have heightened morbidity due to the hyperrespon- 
siveness of macrophages after the transfer of immunocompe- 
tent Pc-sensitized CD4 + T cells (10). Finally, the nonspecific 
host  response to  PVM  may lead to  an  altered balance of 
cytokines critical to the anti-Pc response. For example, TNF-o~ 
produced by alveolar macrophages has been reported to play 
a major role in the control of PCP in AIDS patients (19). 
Human (and bovine) RSV (HRSV) and PVM are classified 
by morphological criteria as unique members of the genus 
Pneumovirus (20) but are reported to either share (21) or not 
share (22) antigenic surface determinants. Recent molecular 
studies have shown weak homology between proteins coded 
by genes 1 and 2 of PVM and analogous genes 1C and 1B 
of HKSV (23).  Thus,  the fatal  synergism of PVM and Pc 
described here may or may not be predictive of similar conse- 
quences in HRSV-Pc dual infections in immunodeficient (e.g., 
AIDS) patients. 
In summary, these results support the broad notion that 
coinfection by secondary microorganisms may have significant 
clinical relevance in terms of diagnosis, prognosis, and therapy 
of primary (e.g., Pc)  opportunistic infection. Further, this 
experimental model may be exploitable for determining the 
fundamental mechanism(s) and effective therapies for such 
detrimental synergy. 
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